For the year ending 2026-01-03, SLAB had $82,615K increase in cash & cash equivalents over the period. $65,786K in free cash flow.
| Cash Flow | 2026-01-03 |
|---|---|
| Net loss | -64,907 |
| Depreciation of property and equipment | 24,716 |
| Amortization of other intangible assets | 13,369 |
| Amortization of debt discount and debt issuance costs | 0 |
| Stock-based compensation expense | 80,324 |
| Equity-method loss | 0 |
| Deferred income taxes | 881 |
| Accounts receivable | 10,034 |
| Inventories | -9,992 |
| Prepaid expenses and other assets | -8,826 |
| Accounts payable | 6,333 |
| Other current liabilities and income taxes | 36,781 |
| Deferred revenue and returns liability | 2,286 |
| Other non-current liabilities | -12,859 |
| Net cash provided by (used in) operating activities | 95,708 |
| Purchases of marketable securities | 34,790 |
| Sales of marketable securities | 15,393 |
| Maturities of marketable securities | 40,716 |
| Purchases of property and equipment | 29,922 |
| Proceeds from capital-related government incentives | 578 |
| Proceeds from sale of equity investment | 0 |
| Purchases of other assets | 4,000 |
| Net cash provided by (used in) investing activities | -12,025 |
| Proceeds from issuance of debt | 0 |
| Payments on debt | 0 |
| Repurchases of common stock | 0 |
| Payment of taxes withheld for vested stock awards | 15,706 |
| Proceeds from the issuance of common stock | 14,638 |
| Net cash used in financing activities | -1,068 |
| Increase (decrease) in cash and cash equivalents | 82,615 |
| Cash and cash equivalents at beginning of period | 281,607 |
| Cash and cash equivalents at end of period | 364,222 |
SILICON LABORATORIES INC. (SLAB)
SILICON LABORATORIES INC. (SLAB)